.biofargo-table-wrapper {overflow-x: auto;margin: 20px 0;-webkit-overflow-scrolling: touch;}.biofargo-spec-table {width: 100%;border-collapse: collapse;border: 1px solid #dee2e6;min-width: 600px;background: #fff;}.biofargo-spec-table th,.biofargo-spec-table td {border: 1px solid #dee2e6;padding: 12px;vertical-align: middle;white-space: normal;word-break: break-word;}@media (max-width: 600px) {.biofargo-table-wrapper {border: 1px solid #eee;border-radius: 8px;padding: 6px;background: #fff;}.biofargo-spec-table {min-width: 720px;}} Description This product is a recombinant adenovirus (AdV) hexon protein, suitable for IVD reagent development, vaccine research, and scientific applications. The hexon protein is the major capsid protein of adenoviruses, is highly immunogenic, and serves as a core target for adenovirus detection and typing. Specifications Product Details Source Human adenovirus C serotype2 Expression Host Mammalian cell Molecular Mass 110.39 kDa Formulation Purified, Liquid Purification >95% Buffer PBS, 5% Mannital, 0.01% Tween80, pH7.4. Storage For long term storage, the product should be stored at -20°C or lower. Validity 3 years Instructions for Use Dissolve the lyophilized powder in an appropriate sterile buffer in a sterile environment before use. Prepare and dilute the solution according to experimental requirements to ensure accurate and reproducible results. Do not mix with other similar products to avoid cross-reactivity and potential interference. Cautions • Research Use Only: This product is not suitable for clinical diagnostics or therapeutic applications. • Preservation: Handle according to instructions to preserve its activity and stability. • Support: Contact our technical support team if you encounter any issues or questions. Documents 📄 Download COA 📄 Download MSDS